Business Context and Reporting Period
This Form 8-K filing by MeiraGTx Holdings Plc, dated October 2, 2018, reports the appointment of a new Chief Financial Officer. The registrant is incorporated in the Cayman Islands and is designated as an emerging growth company.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity metrics. This report focuses exclusively on executive compensation and appointment details.
Material Changes
The primary material change is the appointment of Katherine Breedis as Chief Financial Officer, effective October 2, 2018. No financial performance changes or operational shifts are detailed in this document.
Management Commentary and Compensation Details
- Appointment: Katherine Breedis, age 55, was appointed CFO. She previously served as Managing Director at Stifel Nicolaus & Company and held senior roles at Pfizer Inc. and Eli Lilly & Company.
- Base Salary: $365,000 annually.
- Incentive Compensation: Eligible for a discretionary year-end bonus with a target of 40% of base salary, contingent on company and individual performance.
- Equity Grant: Granted an option to purchase 40,000 ordinary shares under the 2018 Incentive Award Plan.
- Vesting Schedule: 25% vests on October 2, 2019; the remaining 75% vests in 36 equal monthly installments thereafter.
Investor Verification Checklist
- Verify the full text of the Employment Offer Letter (Exhibit 10.1) for additional terms not summarized in the 8-K.
- Confirm the exercise price of the 40,000 stock options granted to the new CFO.
- Review the company's most recent 10-K or 10-Q for current liquidity and cash runway, as this 8-K contains no financial data.
- Monitor future filings for the impact of the new CFO on strategic financial planning and capital allocation.